\BOOKMARK [0][-]{Abstract.0}{Abstract}{}% 1
\BOOKMARK [0][-]{Contents.0}{Contents}{}% 2
\BOOKMARK [0][-]{Dedication.0}{Dedication}{}% 3
\BOOKMARK [0][-]{chapter.1}{Introduction}{}% 4
\BOOKMARK [1][-]{section.1.1}{Cholinergic\040Systems}{chapter.1}% 5
\BOOKMARK [1][-]{section.1.2}{Cholinergic\040Aspects\040of\040Disease}{chapter.1}% 6
\BOOKMARK [2][-]{subsection.1.2.1}{Alzheimer's\040Disease}{section.1.2}% 7
\BOOKMARK [2][-]{subsection.1.2.2}{Schizophrenia\040and\040Bipolar\040Disorder}{section.1.2}% 8
\BOOKMARK [2][-]{subsection.1.2.3}{Immunity}{section.1.2}% 9
\BOOKMARK [2][-]{subsection.1.2.4}{Neuroinflammation}{section.1.2}% 10
\BOOKMARK [2][-]{subsection.1.2.5}{Stroke}{section.1.2}% 11
\BOOKMARK [2][-]{subsection.1.2.6}{Circadian\040Aspects\040of\040Cholinergic\040Systems}{section.1.2}% 12
\BOOKMARK [2][-]{subsection.1.2.7}{Neurokines}{section.1.2}% 13
\BOOKMARK [1][-]{section.1.3}{Transcriptional\040Connectomics}{chapter.1}% 14
\BOOKMARK [2][-]{subsection.1.3.1}{Transcription\040Factors}{section.1.3}% 15
\BOOKMARK [2][-]{subsection.1.3.2}{microRNAs}{section.1.3}% 16
\BOOKMARK [2][-]{subsection.1.3.3}{Transfer\040RNA\040Fragments}{section.1.3}% 17
\BOOKMARK [1][-]{section.1.4}{Nested\040Multimodal\040Transcriptional\040Interactions\040-\040The\040Need\040for\040Connectomics}{chapter.1}% 18
\BOOKMARK [0][-]{chapter.2}{miRNet:\040Creation\040of\040a\040Comprehensive\040Connectomics\040Database}{}% 19
\BOOKMARK [1][-]{section.2.1}{Implementation}{chapter.2}% 20
\BOOKMARK [2][-]{subsection.2.1.1}{Neo4j:\040A\040Graph-Based\040Infrastructure}{section.2.1}% 21
\BOOKMARK [2][-]{subsection.2.1.2}{High-throughput\040Database\040Generation}{section.2.1}% 22
\BOOKMARK [2][-]{subsection.2.1.3}{Maintenance\040and\040Quality\040Control}{section.2.1}% 23
\BOOKMARK [1][-]{section.2.2}{Materials}{chapter.2}% 24
\BOOKMARK [2][-]{subsection.2.2.1}{Gene\040Annotation}{section.2.2}% 25
\BOOKMARK [2][-]{subsection.2.2.2}{microRNA\040Annotation}{section.2.2}% 26
\BOOKMARK [2][-]{subsection.2.2.3}{Transcription\040Factor\040Targeting}{section.2.2}% 27
\BOOKMARK [2][-]{subsection.2.2.4}{microRNA\040Interactions}{section.2.2}% 28
\BOOKMARK [2][-]{subsection.2.2.5}{Filtering\040of\040Aggregated\040Prediction\040Scores}{section.2.2}% 29
\BOOKMARK [2][-]{subsection.2.2.6}{De-novo\040Prediction\040of\040tRF\040Targeting}{section.2.2}% 30
\BOOKMARK [2][-]{subsection.2.2.7}{microRNA\040Primate\040Specificity}{section.2.2}% 31
\BOOKMARK [1][-]{section.2.3}{miRNet\040Usage}{chapter.2}% 32
\BOOKMARK [1][-]{section.2.4}{Statistical\040Approach\040to\040Transcriptional\040Connectomics}{chapter.2}% 33
\BOOKMARK [2][-]{subsection.2.4.1}{Permutation}{section.2.4}% 34
\BOOKMARK [2][-]{subsection.2.4.2}{Gene\040Set\040Enrichment\040Analysis}{section.2.4}% 35
\BOOKMARK [0][-]{chapter.3}{microRNA\040Dynamics\040in\040Cholinergic\040Differentiation\040of\040Human\040Neuronal\040Cells}{}% 36
\BOOKMARK [1][-]{section.3.1}{Neuronal\040Transcriptomes\040-\040Background}{chapter.3}% 37
\BOOKMARK [1][-]{section.3.2}{Cortical\040Single-Cell\040RNA\040Sequencing}{chapter.3}% 38
\BOOKMARK [1][-]{section.3.3}{microRNA\040and\040Transcription\040Factor\040Targeting\040Predictions}{chapter.3}% 39
\BOOKMARK [1][-]{section.3.4}{Gene\040Clustering\040Based\040On\040Expression}{chapter.3}% 40
\BOOKMARK [2][-]{subsection.3.4.1}{Co-Expression\040of\040Functional\040Groups\040of\040Cholinergic\040Genes}{section.3.4}% 41
\BOOKMARK [1][-]{section.3.5}{The\040Cellular\040Model}{chapter.3}% 42
\BOOKMARK [2][-]{subsection.3.5.1}{The\040SH-SY5Y\040Neuroblastoma\040Cell\040Line}{section.3.5}% 43
\BOOKMARK [2][-]{subsection.3.5.2}{The\040LA-N\040Neuroblastoma\040Cell\040Lines}{section.3.5}% 44
\BOOKMARK [2][-]{subsection.3.5.3}{Culture}{section.3.5}% 45
\BOOKMARK [2][-]{subsection.3.5.4}{Differentiation}{section.3.5}% 46
\BOOKMARK [2][-]{subsection.3.5.5}{RNA\040Isolation}{section.3.5}% 47
\BOOKMARK [1][-]{section.3.6}{Small\040RNA\040Sequencing\040and\040Differential\040Expression\040Analysis}{chapter.3}% 48
\BOOKMARK [2][-]{subsection.3.6.1}{Sequencing}{section.3.6}% 49
\BOOKMARK [2][-]{subsection.3.6.2}{Sequence\040Alignment}{section.3.6}% 50
\BOOKMARK [2][-]{subsection.3.6.3}{Differential\040Expression\040Analysis\040-\040R/DESeq2}{section.3.6}% 51
\BOOKMARK [2][-]{subsection.3.6.4}{microRNA\040Dynamics\040in\040CNTF-mediated\040Cholinergic\040Differentiation\040of\040LA-N-2\040and\040LA-N-5}{section.3.6}% 52
\BOOKMARK [2][-]{subsection.3.6.5}{microRNA\040Family\040Enrichment}{section.3.6}% 53
\BOOKMARK [1][-]{section.3.7}{microRNA\040Family\040Gene\040Ontology\040Enrichment}{chapter.3}% 54
\BOOKMARK [2][-]{subsection.3.7.1}{Creation\040of\040miRNA\040Family\040Gene\040Target\040Sets}{section.3.7}% 55
\BOOKMARK [2][-]{subsection.3.7.2}{GO\040Analysis\040of\040Target\040Sets}{section.3.7}% 56
\BOOKMARK [2][-]{subsection.3.7.3}{Large\040Scale\040GO\040Term\040Curation}{section.3.7}% 57
\BOOKMARK [1][-]{section.3.8}{Whole\040Genome\040miRNAGene\040Network\040Generation}{chapter.3}% 58
\BOOKMARK [1][-]{section.3.9}{Application\040to\040Schizophrenia\040and\040Bipolar\040Disorder}{chapter.3}% 59
\BOOKMARK [2][-]{subsection.3.9.1}{Analysed\040Datasets}{section.3.9}% 60
\BOOKMARK [2][-]{subsection.3.9.2}{Microarray\040Quality\040Control\040and\040Data\040Preparation}{section.3.9}% 61
\BOOKMARK [2][-]{subsection.3.9.3}{Differential\040Expression\040Meta-Analysis}{section.3.9}% 62
\BOOKMARK [2][-]{subsection.3.9.4}{Sexual\040Dimorphism\040in\040Schizophrenia\040and\040Bipolar\040Disorder}{section.3.9}% 63
\BOOKMARK [2][-]{subsection.3.9.5}{Combination\040of\040Disease\040Data\040and\040Cell\040Culture}{section.3.9}% 64
\BOOKMARK [2][-]{subsection.3.9.6}{miR-125b-5p\040Acetylcholinesterase\040Targeting\040Assays}{section.3.9}% 65
\BOOKMARK [2][-]{subsection.3.9.7}{hsa-miR-125b-5p\040Targets\040Acetylcholinesterase}{section.3.9}% 66
\BOOKMARK [2][-]{subsection.3.9.8}{Cholinergic/Neurokine\040Mechanisms\040in\040Web-Available\040RNA\040Sequencing\040Experiments}{section.3.9}% 67
\BOOKMARK [0][-]{chapter.4}{Discussion}{}% 68
\BOOKMARK [1][-]{section.4.1}{Methods}{chapter.4}% 69
\BOOKMARK [1][-]{section.4.2}{The\040Cholinergic/Neurokine\040Interface}{chapter.4}% 70
\BOOKMARK [1][-]{section.4.3}{Small\040RNA\040Therapeutics\040and\040Pharmacology}{chapter.4}% 71
\BOOKMARK [0][-]{chapter.5}{Conclusion}{}% 72
\BOOKMARK [0][-]{chapter*.50}{References}{}% 73
\BOOKMARK [0][-]{appendix.A}{Transcription\040Factor\040Regulatory\040Circuits\040-\040Tissue\040Types}{}% 74
\BOOKMARK [0][-]{appendix.B}{List\040of\040Primate-Specific\040Homologues\040of\040Human\040microRNAs}{}% 75
\BOOKMARK [0][-]{appendix.C}{microRNA\040Differential\040Expression\040in\040LA-N-2\040and\040LA-N-5}{}% 76
